Drug delivery to certain eye tissues has long been a major challenge for ocular scientists. Some problems with the standard formulations of drug solutions given as topical drops led to the introduction of various carrier systems for ocular dispersion. A lot of work is being done on ocular research to create safe, novel, and patient-friendly methods of pharmaceutical administration. After being enclosed in nanoscale carrier systems or devices, drug molecules are administered using invasive, non-invasive, or minimally invasive techniques. In the years to come, drug delivery may be greatly enhanced by the creation of non-invasive sustained drug delivery devices and studies into the viability of topical application to deliver medications to the posterior region. The difficulties related to a number of anterior and posterior segment diseases may be significantly reduced by recent advancements in the administration of ocular medications.
No takes yet. Share an insight, caveat, or question.
Shivam Dubey (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: